GILD vs SSTI · P/E 18, rev $7.80B vs rev $48.1M
Gilead Sciences Inc (GILD) versus Shotspotter Inc (SSTI) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Shotspotter Inc (SSTI) is a software - application company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SSTI revenue for 2026-06-30 was $48.1M. Net income was -$11.8M. Revenue was up 98.8% from 2026-03-31 to 2026-06-30. SSTI currently screens at market cap $98.3M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SSTI currently screens at market cap $98.3M.
Not investment advice. Open the GILD and SSTI stock pages for the full models.
Not investment advice.